The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Randomized phase III study comparing FOLFOX + bevacizumab versus folfoxiri + bevacizumab (BEV) as 1st line treatment in patients with metastatic colorectal cancer (mCRC) with ≥3 baseline circulating tumor cells (bCTCs).
 
Javier Sastre
No Relationships to Disclose
 
Jose María Vieitez
Consulting or Advisory Role - Roche, Amgen, Servier
Research Funding - Amgen; Roche
Expert Testimony - SERVIER
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Roche; SERVIER
 
Maria Auxilidora Gomez-España
Travel, Accommodations, Expenses - Amgen; Merck; Roche; SERVIER
 
Silvia Gil Calle
No Relationships to Disclose
 
Antonieta Salud Salvia
No Relationships to Disclose
 
Begoña Graña Suárez
Consulting or Advisory Role - Celgene; Sanofi
Research Funding - Celgene; Erytech Pharma; Gilead Sciences; Lilly; PAREXEL; Sanofi
Travel, Accommodations, Expenses - Amgen; Celgene; Roche; Sanofi; SERVIER
 
Pilar Garcia-Alfonso
No Relationships to Disclose
 
Eva Martinez de Castro
No Relationships to Disclose
 
Guillermo Alfonso Quintero Aldana
No Relationships to Disclose
 
Juan José Reina-Zoilo
Consulting or Advisory Role - Amgen; Archimedes; Bayer; Ipsen; Merck; Novartis; Pfizer; Prostrakan; Roche; Sanofi; SERVIER
Travel, Accommodations, Expenses - Amgen; Bayer; Ipsen; Merck; Novartis; Prostrakan; Roche; Sanofi; SERVIER
 
Encarnación González Flores
No Relationships to Disclose
 
Mercedes Salgado Fernández
No Relationships to Disclose
 
Carmen Guillen
Speakers' Bureau - Bayer; BTG; Celgene; Fresenius Kabi; Merck Serono; Nutricia; Sanofi/Aventis; SERVIER
Travel, Accommodations, Expenses - Bayer; BTG; Celgene; Merck Serono; Sanofi/Aventis
 
Rocio Garcia-Carbonero
No Relationships to Disclose
 
Maria Jose Safont
Consulting or Advisory Role - Merck; Roche; Sanofi; Servier
Travel, Accommodations, Expenses - Amgen; Merck; Roche
 
Adelaida La Casta Munoa
Travel, Accommodations, Expenses - Amgen; Amgen
 
Beatriz García de Paredes
No Relationships to Disclose
 
Rafael Lopez
Stock and Other Ownership Interests - MTrap; Nasasbiotech
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Janssen; lilly; MSD; Roche
Speakers' Bureau - Novartis; Roche
Research Funding - Lilly (Inst); Merck (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Pierre Fabre; Roche; Tesaro
 
Enrique Aranda
Consulting or Advisory Role - Amgen; Bayer; Celgene; Merck; Roche; Sanofi
 
Eduardo Díaz-Rubio
Consulting or Advisory Role - Amgen; Bayer; Genomica; Merck Serono; SERVIER
Speakers' Bureau - MSD; SERVIER
Research Funding - Amgen; AstraZeneca; Merck Serono; Roche; Sysmex